Table 4. Pathological and molecular detains in 8 patients with recurrent HCC.
Case No. | Stage (primary) | ES grade (primary/recurrent) | Vascular invasion (primary/recurrent) | Tumor multiplicity (primary/recurrent) | TERT mutation (primary/recurrent) | CTNNB1 mutation (primary/recurrent) |
---|---|---|---|---|---|---|
1 | 4 | 3/4 | Micorvascular/Micorvascular invasion | No/No | Wild/Wild | Mutant/Mutant |
2 | 2 | 3/2 | No / No invasion | Yes/No | Wild/ND | Wild/Wild |
3 | 1 | 3/2 | No / No invasion | Yes/Yes | Wild/Wild | Wild/Wild |
4 | 3a | 2/3 | Macrovascular / No invasion | Yes/Yes | Wild/Wild | Wild/ND |
5 | 2 | 3/2 | Microvascular / No invasion | Yes/No | Wild/Mutant | Wild/Wild |
6 | 2 | 2/2 | No / No invasion | No/No | Wild/Mutant | Wild/Wild |
7 | 2 | 3/3 | No / No invasion | Yes/Yes | Mutant/Mutant | Wild/Wild |
8 | 1 | 3/3 | No / No invasion | No/No | Wild/Wild | Wild/Wild |